Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, Villà S, Poortmans PM, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A; Rare Cancer Network.
Goldberg H, et al. Among authors: lavie o.
Gynecol Oncol. 2008 Feb;108(2):298-305. doi: 10.1016/j.ygyno.2007.10.037. Epub 2007 Dec 21.
Gynecol Oncol. 2008.
PMID: 18096209